Australia’s health regulator, the Therapeutic Goods Administration (TGA), has launched legal action against News Corp Australia-owned News Life Media, Mamamia.com.au, AG Therapeutics, and public relations firm Straight Up PR for allegedly breaching medicinal cannabis advertising laws.
The TGA is seeking financial penalties, claiming the companies unlawfully advertised prescription-only cannabis products, violating the Therapeutic Goods Act 1989. The Act strictly prohibits the promotion of prescription medicines, including medicinal cannabis, to the public without prior authorization.
According to the TGA, articles published by News Life Media and Mamamia featured illegal testimonials and endorsements from healthcare professionals and individuals associated with patients, which are banned under Australian advertising codes. The watchdog also accused AG Therapeutics of using euphemisms like “plant medicine” in its marketing while promoting cannabis as a treatment for serious health conditions across its website and social media platforms.
TGA head Anthony Lawler said the parties involved had previously received multiple warnings regarding the unlawful promotion of therapeutic goods. Despite these alerts, the alleged advertising continued.
News Corp Australia, a unit of global media giant News Corp (NASDAQ:NWSA), has not responded to media inquiries about the proceedings. The case highlights the growing scrutiny over cannabis advertising and the regulator’s commitment to enforcing compliance in the rapidly expanding medicinal cannabis sector.
The lawsuit signals a warning to media outlets, natural health brands, and PR firms engaging in unapproved promotions of prescription therapies. As cannabis becomes more mainstream in Australia, businesses are urged to align with legal frameworks to avoid regulatory penalties and reputational damage.
This case also emphasizes the importance of responsible marketing in the health and wellness industry, particularly when dealing with prescription-only products like medicinal cannabis.


HSBC Australia Faces A$35M Penalty Over Scam Protection Failures
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence
Brazil Supreme Court Convicts Eduardo Bolsonaro Over U.S. Lobbying Efforts
Why the future of marijuana legalization remains hazy despite high public support
DOJ Clears Paramount Skydance-Warner Bros. Discovery Merger Without Conditions
Kennedy Center Ordered to Remove Trump Name Following Federal Court Ruling
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy
ICC Judges Sue Trump Administration Over Sanctions, Calling Measures Unlawful
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge
ICC Prosecutor Karim Khan Suspended as Member States Consider Removal 



